Table 1: Baseline characteristics of participants.
Variables |
Effective (N = 27) |
Percentage |
Sex (male) |
12 |
44.4 |
Age (years) |
|
|
(25-45) |
2 |
7.4 |
(45-65) |
19 |
70.4 |
≥ 65 |
6 |
22.2 |
Comorbidity |
|
|
High blood pressure |
8 |
29.6 |
Diabetes |
7 |
26 |
Gout |
2 |
7.4 |
Chronic kidney disease |
1 |
3.7 |
≥ 2 comorbidities |
6 |
22 |
Medications |
|
|
Angiotensin blocker |
8 |
29.6 |
Metformin |
5 |
18.5 |
Diuretic |
3 |
11 |
HCV Genotype |
|
|
1 |
7 |
26 |
4 |
5 |
18.5 |
Unknown |
15 |
55.5 |
Baseline Biological data* |
|
|
Haemoglobin (g/dl) |
12.9 ± 1.3 |
- |
Alanine aminotransferase (UI/l) |
67 (45.7-79.0) |
- |
Aspartate aminotransferase (UI/l) |
55.0 (IQR 46.0-80.0) |
- |
Median viral load (× 106 copy/mm3) |
1.1 (IQR 0.7-2.25) |
|
Creatinine (mg/dl) |
1.02 (IQR 0.83-1.17) |
- |
eGFR (ml/min/1.73 m2) |
82.4 ± 20.6 |
|
*Means ± standard deviation or median (25th -75th interquartile range); eGFR: Estimated glomerular filtration rate.